Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Haihong Hu, Taolan Zhang, Yiwen Wu, Meina Deng, Huiling Deng & Xiaoyan Yang. (2022) Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 16:8, pages 753-765.
Read now
Read now
Mengjie Rui, Yang Qu, Tong Gao, Yanru Ge, Chunlai Feng & Ximing Xu. (2017) Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells. International Journal of Nanomedicine 12, pages 217-237.
Read now
Read now
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan & Liu Hong. (2017) Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 11:12, pages 1151-1163.
Read now
Read now
Chun-Xia Ren, Rui-Xue Leng, Yin-Guang Fan, Hai-Feng Pan, Chang-Hao Wu & Dong-Qing Ye. (2016) MicroRNA-210 and its theranostic potential. Expert Opinion on Therapeutic Targets 20:11, pages 1325-1338.
Read now
Read now
Liu Hong, Yu Han, Hongwei Zhang & Daiming Fan. (2015) Prognostic markers in esophageal cancer: from basic research to clinical use. Expert Review of Gastroenterology & Hepatology 9:7, pages 887-889.
Read now
Read now
Liu Hong, Yu Han, Jianjun Yang, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance. Expert Opinion on Biological Therapy 14:8, pages 1103-1111.
Read now
Read now
Liu Hong, Yu Han, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) Prognosis-related microRNAs in esophageal cancer. Expert Opinion on Biological Therapy 14:4, pages 483-489.
Read now
Read now
Liu Hong, Yu Han, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) Drug resistance-related miRNAs in hepatocellular cancer. Expert Review of Gastroenterology & Hepatology 8:3, pages 283-288.
Read now
Read now
Articles from other publishers (67)
Michaela B. Kirschner, Harriet R. Walker & Hannah L. Moody. 2023. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
85
107
.
Mostafa Vaghari-Tabari, Parisa Hassanpour, Fatemeh Sadeghsoltani, Faezeh Malakoti, Forough Alemi, Durdi Qujeq, Zatollah Asemi & Bahman Yousefi. (2022) CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Thiruganesh Ramasamy, Hima Bindu Ruttala, Shankar Munusamy, Nilay Chakraborty & Jong Oh Kim. (2022) Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics. Journal of Controlled Release 352, pages 861-878.
Crossref
Crossref
Yubin Pan, Honglin Tang, Qijun Li, Guangpeng Chen & Da Li. (2022) Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Medicine 11:24, pages 4979-4988.
Crossref
Crossref
Tara Akhtarkhavari, Ahmad Reza Bahrami & Maryam M. Matin. (2022) Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer. European Journal of Pharmacology 932, pages 175233.
Crossref
Crossref
Sepideh Sadighbathi & Ahmad Mobed. (2022) Genosensors, a nanomaterial-based platform for microRNA-21 detection, non-invasive methods in early detection of cancer. Clinica Chimica Acta 530, pages 27-38.
Crossref
Crossref
Abolfazl Shakeri, Mohsen Ghanbari, Aida Tasbandi & Amirhossein Sahebkar. (2021)
Regulation of
microRNA
‐21 expression by natural products in cancer
. Phytotherapy Research 35:7, pages 3732-3746.
Crossref
Crossref
Min Hong, Hongxiao Sun, Qiangqiang Yang, Shuang Cheng, Shuxian Yu, Shuhua Fan, Chuan Li, Cheng Cui & Weihong Tan. (2021) A microRNA-21-responsive doxorubicin-releasing sticky-flare for synergistic anticancer with silencing of microRNA and chemotherapy. Science China Chemistry 64:6, pages 1009-1019.
Crossref
Crossref
Ha Thi Nguyen, Salah Eddine Oussama Kacimi, Truc Ly Nguyen, Kamrul Hassan Suman, Roselyn Lemus-Martin, Humaira Saleem & Duy Ngoc Do. (2021) MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology 10:5, pages 417.
Crossref
Crossref
Zhu-Jun Law, Xin Hui Khoo, Pei Tee Lim, Bey Hing Goh, Long Chiau Ming, Wai-Leng Lee & Hui Poh Goh. (2021) Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Arkadiusz Kajdasz, Weronika Majer, Katarzyna Kluzek, Jacek Sobkowiak, Tomasz Milecki, Natalia Derebecka, Zbigniew Kwias, Hans A. R. Bluyssen & Joanna Wesoly. (2021) Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data. Cancers 13:3, pages 548.
Crossref
Crossref
Tanu Sharma, James A. Radosevich & Chandi C. Mandal. (2021) Dual Role of microRNAs in Autophagy of Colorectal Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:1, pages 56-66.
Crossref
Crossref
Shusuke Toden, Timothy J. Zumwalt & Ajay Goel. (2021) Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188491.
Crossref
Crossref
Khushbukhat Khan, Cristina Quispe, Zeeshan Javed, Muhammad Javed Iqbal, Haleema Sadia, Shahid Raza, Asma Irshad, Bahare Salehi, Željko Reiner & Javad Sharifi-Rad. (2020) Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer. Cancer Cell International 20:1.
Crossref
Crossref
Yuanming Jing, Wenqing Liang, Jian Liu, Lin Zhang, Jianguo Wei, Jianhui Yang, Yu Zhang & Zongliang Huang. (2020) Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biology and Toxicology 36:6, pages 517-536.
Crossref
Crossref
Wei He, Annie Turkeshi, Xiaotong Li & Hongwei Zhang. (2020) Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles. Therapeutic Delivery 11:9, pages 591-603.
Crossref
Crossref
Bhagyashri Kulkarni, Piyush Gondaliya, Prathibha Kirave, Rakesh Rawal, Alok Jain, Rachana Garg & Kiran Kalia. (2020) Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget 11:20, pages 1832-1845.
Crossref
Crossref
Shiva Najjary, Reza Mohammadzadeh, Ahad Mokhtarzadeh, Ali Mohammadi, Amir Baghbanzadeh Kojabad & Behzad Baradaran. (2020) Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer. Gene 738, pages 144453.
Crossref
Crossref
Weidong Li, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, Xian Jiang, Chang Liu, Hongchi Jiang & Xueying Sun. (2019) LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Zhi‑Ying Li, Zi‑Zhou Zhang, Hui Bi, Qiu‑Di Zhang, Su‑Juan Zhang, Lin Zhou, Xiao‑Qin Zhu & Jun Zhou. (2019) MicroRNA‑4500 suppresses tumor progression in non‑small cell lung cancer by regulating STAT3. Molecular Medicine Reports.
Crossref
Crossref
Chen, Hsieh, Lo, Li, Chou & Yang. (2019) In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells. Biomolecules 9:9, pages 467.
Crossref
Crossref
Yanxin Fan, Xiuhua Bian, Pudong Qian, Jing Wen, Pengwei Yan, Yanhong Luo, Jing Wu & Qian Zhang. (2019) MiRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor. Molecular Medicine Reports.
Crossref
Crossref
Nataly Naser Al Deen, Farah Nassar, Rihab Nasr & Rabih Talhouk. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
335
364
.
Takuma Goto, Mikihiro Fujiya, Hiroaki Konishi, Junpei Sasajima, Shugo Fujibayashi, Akihiro Hayashi, Tatsuya Utsumi, Hiroki Sato, Takuya Iwama, Masami Ijiri, Aki Sakatani, Kazuyuki Tanaka, Yoshiki Nomura, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Yusuke Mizukami, Yutaka Kohgo & Toshikatsu Okumura. (2018) An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer 18:1.
Crossref
Crossref
Rongrong Liao, Yuexia Lin & Lihui Zhu. (2018) Molecular pathways involved in microRNA-mediated regulation of multidrug resistance. Molecular Biology Reports 45:6, pages 2913-2923.
Crossref
Crossref
Chao Wang, Ting Li, Fei Yan, Wenyan Cai, Jiwei Zheng, Xingyu Jiang & Jinhu Sun. (2018) Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma. Biomedicine & Pharmacotherapy 105, pages 1054-1061.
Crossref
Crossref
Charbel Darido, Smitha R. Georgy, Carleen Cullinane, Darren D. Partridge, Rachael Walker, Seema Srivastava, Suraya Roslan, Marina R. Carpinelli, Sebastian Dworkin, Richard B. Pearson & Stephen M. Jane. (2017) Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin. Cell Death & Differentiation 25:6, pages 1146-1159.
Crossref
Crossref
Ying-kui Song, Yang Wang, Yi-yang Wen, Pei Zhao & Zhi-jie Bian. (2018) RETRACTED: MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS. Technology in Cancer Research & Treatment 17, pages 153303381880999.
Crossref
Crossref
Xin Liu, Xianping Lv, Qiankun Yang, Huifang Jin, Wenpeng Zhou & Qingxia Fan. (2018) MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer. Technology in Cancer Research & Treatment 17, pages 153303381875890.
Crossref
Crossref
Jing Ma, Wei Gong, Su Liu, Qian Li, Mengzheng Guo, Jinhan Wang, Suying Wang, Naiyao Chen, Yafei Wang, Qiang Liu & Hui Zhao. (2018) Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3. Tumor Biology 40:1, pages 101042831773136.
Crossref
Crossref
Ning Xu, Yan-Jun Lian, Xiang Dai & Yuan-Jie Wang. (2017) miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR. Technology in Cancer Research & Treatment 16:6, pages 1022-1030.
Crossref
Crossref
Yincheng Liu, Yichun Wang, Qitong Xu, Xiang Zhou, Zhiqiang Qin, Chen Chen, Qijie Zhang, Ye Tian, Chao Zhang, Xiao Li & Chao Qin. (2017) Prognostic evaluation of microRNA-210 in various carcinomas. Medicine 96:43, pages e8113.
Crossref
Crossref
Xiaoyang Li, Jacson K. Shen, Francis J. Hornicek, Tao Xiao & Zhenfeng Duan. (2017) Noncoding RNA in drug resistant sarcoma. Oncotarget 8:40, pages 69086-69104.
Crossref
Crossref
Xiaomin Yu, Yulong Chen, Ruiyun Tian, Jianxia Li, Hongyan Li, Teng Lv & Qin Yao. (2017) miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN. Oncology Letters 14:2, pages 1807-1810.
Crossref
Crossref
Yaqing Li, Yinting Chen, Jiajia Li, Zuoquan Zhang, Chumei Huang, Guoda Lian, Kege Yang, Shaojie Chen, Ying Lin, Lingyun Wang, Kaihong Huang & Linjuan Zeng. (2017) Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Cancer Science 108:7, pages 1493-1503.
Crossref
Crossref
Ming Qi, Dongmei Liu & Shuhong Zhang. (2017) MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer. Cancer Biomarkers 18:4, pages 451-458.
Crossref
Crossref
E Manara, G Basso, M Zampini, B Buldini, C Tregnago, R Rondelli, R Masetti, V Bisio, M Frison, K Polato, G Cazzaniga, G Menna, F Fagioli, P Merli, A Biondi, A Pession, F Locatelli & M Pigazzi. (2016) Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group. Leukemia 31:1, pages 18-25.
Crossref
Crossref
Shuyao Tang, Gang Tan, Xian Jiang, Peng Han, Bo Zhai, Xuesong Dong, Haiquan Qiao, Hongchi Jiang & Xueying Sun. (2016) An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells. Oncotarget 7:45, pages 73257-73269.
Crossref
Crossref
Yin-Hsun Feng & Chao-Jung Tsao. (2016) Emerging role of microRNA-21 in cancer. Biomedical Reports 5:4, pages 395-402.
Crossref
Crossref
Sayan Mullick Chowdhury, Tzu-Yin Wang, Sunitha Bachawal, Rammohan Devulapally, Jung Woo Choe, Lotfi Abou Elkacem, Butrus Khuri Yakub, David S. Wang, Lu Tian, Ramasamy Paulmurugan & Jürgen K. Willmann. (2016) Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. Journal of Controlled Release 238, pages 272-280.
Crossref
Crossref
Yan-Ran Wu, Hai-Jun Qi, Dan-Fang Deng, Ying-Ying Luo & Sheng-Lan Yang. (2016) MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumor Biology 37:9, pages 12061-12070.
Crossref
Crossref
Hamid Hashemi‐Moghaddam, Mansooreh Kashi, Seyed Javad Mowla & Nazila Nouraee. (2016) Separation of microRNA 21 as a cancer marker from glioblastoma cell line using molecularly imprinted polymer coated on silica nanoparticles. Journal of Separation Science 39:18, pages 3564-3570.
Crossref
Crossref
R Schreiber, R Mezencev, L V Matyunina & J F McDonald. (2016) Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells. Cancer Gene Therapy 23:8, pages 241-245.
Crossref
Crossref
Aamir Ahmad, Yiwei Li & Fazlul H. Sarkar. (2016) The bounty of nature for changing the cancer landscape. Molecular Nutrition & Food Research 60:6, pages 1251-1263.
Crossref
Crossref
Xueju Wei, Weibin Wang, Lanlan Wang, Yuanyuan Zhang, Xian Zhang, Mingtai Chen, Fang Wang, Jia Yu, Yanni Ma & Guotao Sun. (2016)
Micro
RNA
‐21 induces 5‐fluorouracil resistance in human pancreatic cancer cells by regulating
PTEN
and
PDCD
4
. Cancer Medicine 5:4, pages 693-702.
Crossref
Crossref
HAIBIN SUN, PANZHI WANG, QIANGNU ZHANG, XIAOYAN HE, GUOZHEN ZAI, XUDONG WANG, MEI MA & XIAOLI SUN. (2016) MicroRNA-21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa. Molecular Medicine Reports 13:3, pages 2701-2707.
Crossref
Crossref
Yeheli Ravid, Malka Formanski, Yoav Smith, Reuven Reich & Ben Davidson. (2016) Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecologic Oncology 140:3, pages 512-517.
Crossref
Crossref
Lingling Guo, Yongsheng Zhang, Lifeng Zhang, Fengbo Huang, Jinfan Li & Shouli Wang. (2015) MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumor Biology 37:1, pages 115-125.
Crossref
Crossref
Zhaoli HanXintong GeJin TanFanglian ChenHuabin GaoPing LeiJianning Zhang. (2015)
Establishment of Lipofection Protocol for Efficient miR-21 Transfection into Cortical Neurons
In Vitro
. DNA and Cell Biology 34:12, pages 703-709.
Crossref
Crossref
Vasudha Sehgal, Elena G. Seviour, Tyler J. Moss, Gordon B. Mills, Robert Azencott & Prahlad T. Ram. (2015) Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers. PLOS ONE 10:10, pages e0140072.
Crossref
Crossref
Changjun He, Xuesong Dong, Bo Zhai, Xian Jiang, Deli Dong, Baoxin Li, Hongchi Jiang, Shidong Xu & Xueying Sun. (2015) MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Oncotarget 6:30, pages 28867-28881.
Crossref
Crossref
Mugdha Harmalkar, Shailendra Upraity, Sadaf Kazi & Neelam Vishwanath Shirsat. (2015) Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition. Journal of Molecular Neuroscience 57:2, pages 197-202.
Crossref
Crossref
Ying Wang, Kaichun Wu, Zhiping Yang, Qingchuan Zhao, Dongmei Fan, Po Xu, Yongzhan Nie & Daiming Fan. (2015) Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer. PLOS ONE 10:8, pages e0135461.
Crossref
Crossref
Paul Zarogoulidis, Savvas Petanidis, Efrosini Kioseoglou, Kalliopi Domvri, Doxakis Anestakis & Konstantinos Zarogoulidis. (2015) MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells. Cellular Signalling 27:8, pages 1576-1588.
Crossref
Crossref
Jennifer F. Barger & S. Patrick Nana-Sinkam. (2015) MicroRNA as tools and therapeutics in lung cancer. Respiratory Medicine 109:7, pages 803-812.
Crossref
Crossref
Kailiu Wu, Liwen Li & Siyi Li. (2014) Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies. Tumor Biology 36:3, pages 1973-1981.
Crossref
Crossref
Peter Igaz, Ivan Igaz, Zoltán Nagy, Gábor Nyírő, Peter M. Szabó, András Falus, Attila Patócs & Károly Rácz. (2014) MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy. Cellular and Molecular Life Sciences 72:3, pages 417-428.
Crossref
Crossref
Stephen G. Maher, Becky A.S. Bibby, Hannah L. Moody & Glen Reid. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
67
90
.
Gary B. Fogel, Ana D. Lopez, Zoya Kai & Charles C. King. 2015. Information Processing in Cells and Tissues. Information Processing in Cells and Tissues
145
152
.
Ivan Igaz & Peter Igaz. 2015. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance
269
280
.
Ivan Igaz & Peter Igaz. (2014) Tumor surveillance by circulating microRNAs: a hypothesis. Cellular and Molecular Life Sciences 71:21, pages 4081-4087.
Crossref
Crossref
Boye Schnack Nielsen, Eva Balslev, Tim Svenstrup Poulsen, Dorte Nielsen, Trine Møller, Christiane Ehlers Mortensen, Kim Holmstrøm & Estrid Høgdall. (2014) miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Chang Gong, Yan Nie, Shaohua Qu, Jian-You Liao, Xiuying Cui, Herui Yao, Yunjie Zeng, Fengxi Su, Erwei Song & Qiang Liu. (2014)
miR-21
Induces Myofibroblast Differentiation and Promotes the Malignant Progression of Breast Phyllodes Tumors
. Cancer Research 74:16, pages 4341-4352.
Crossref
Crossref
Jing Ma, Su Liu & Yafei Wang. (2014) MicroRNA-21 and multiple myeloma: small molecule and big function. Medical Oncology 31:8.
Crossref
Crossref
V. P. Sivadas & S. Kannan. (2013) The microRNA networks of TGFβ signaling in cancer. Tumor Biology 35:4, pages 2857-2869.
Crossref
Crossref
Jiri Sana, Andrej Besse & Ondrej Slaby. 2014. Glioma Cell Biology. Glioma Cell Biology
77
116
.
Vincent A. Funari, Michael Winkler, Jordan Brown, Slobodan D. Dimitrijevich, Alexander V. Ljubimov & Mehrnoosh Saghizadeh. (2013) Differentially Expressed Wound Healing-Related microRNAs in the Human Diabetic Cornea. PLoS ONE 8:12, pages e84425.
Crossref
Crossref